paclitaxel has been researched along with Cancer of Pharynx in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, SG; Kim, SA; Lee, MR; Yoon, JH | 1 |
Au, JL; Gan, Y; Johnston, J; Mo, Y; Song, S; Wientjes, MG; Xiao, X | 1 |
Alvarez Marcos, CA; de Bock, GH; Gibcus, JH; Hermsen, MA; Kluin, PM; Kok, K; Langendijk, JA; Mastik, MF; Menkema, L; Schuuring, E; Takes, RP; van den Brekel, MW; van der Laan, BF; van der Wal, JE; van Velthuysen, ML | 1 |
Bruno, A; Damascelli, B; Di Tolla, G; Frigerio, LF; Garbagnati, F; Lanocita, R; Marchianò, A; Mattavelli, F; Patelli, G; Spreafico, C; Tichá, V; Zunino, F | 1 |
Au, JL; Walsh, CT; Wei, Y; Wientjes, MG | 1 |
Au, JL; Jang, SH; Kuh, HJ; Weaver, JR; Wientjes, MG | 1 |
1 trial(s) available for paclitaxel and Cancer of Pharynx
Article | Year |
---|---|
Feasibility and efficacy of percutaneous transcatheter intraarterial chemotherapy with paclitaxel in albumin nanoparticles for advanced squamous-cell carcinoma of the oral cavity, oropharynx, and hypopharynx.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Catheterization; Drug Carriers; Feasibility Studies; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Nanoparticles; Paclitaxel; Pharyngeal Neoplasms; Pilot Projects; Serum Albumin; Treatment Outcome | 2007 |
5 other study(ies) available for paclitaxel and Cancer of Pharynx
Article | Year |
---|---|
HOXC6 regulates the antitumor effects of pheophorbide a-based photodynamic therapy in multidrug-resistant oral cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Chlorophyll; Combined Modality Therapy; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Homeodomain Proteins; Humans; Mice; Mice, Inbred C3H; Paclitaxel; Pharyngeal Neoplasms; Pharynx; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2016 |
Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Synergism; Humans; In Situ Hybridization, Fluorescence; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Osteosarcoma; Paclitaxel; Pharyngeal Neoplasms; RNA, Antisense; Telomerase; Telomere; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Zidovudine | 2003 |
Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma; Cell Cycle; Chromosome Aberrations; Chromosome Mapping; Chromosomes, Human, Pair 11; Fas-Associated Death Domain Protein; Gene Expression Profiling; Humans; Laryngeal Neoplasms; Nucleic Acid Hybridization; Paclitaxel; Pharyngeal Neoplasms; Phosphorylation; Time Factors | 2007 |
Quantitative image analysis of intra-tumoral bFGF level as a molecular marker of paclitaxel resistance.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Enzyme-Linked Immunosorbent Assay; Female; Fibroblast Growth Factor 2; HT29 Cells; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Inhibitory Concentration 50; Male; Mice; Mice, SCID; Paclitaxel; Pancreatic Neoplasms; Pharyngeal Neoplasms; Prostatic Neoplasms; Sensitivity and Specificity; Statistics as Topic; Tissue Culture Techniques; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2008 |
Determinants of paclitaxel penetration and accumulation in human solid tumor.
Topics: Animals; Antineoplastic Agents, Phytogenic; Autoradiography; Culture Techniques; Diffusion; Female; Half-Life; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Mice; Neoplasms; Ovarian Neoplasms; Paclitaxel; Pharyngeal Neoplasms; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured | 1999 |